Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend

Core Viewpoint - Select Medical Holdings Corporation reported significant growth in revenue and income for the fourth quarter and full year ended December 31, 2025, alongside a positive business outlook for 2026 and the declaration of a cash dividend [1][2]. Financial Performance - For Q4 2025, revenue increased by 6.4% to $1,396.6 million from $1,312.6 million in Q4 2024 [1]. - Income from continuing operations before other income and expense surged by 203.1% to $63.9 million compared to $21.1 million in the prior year [1]. - Net income from continuing operations, net of tax, rose by 461.0% to $37.7 million, reversing a loss of $10.5 million in Q4 2024 [1]. - Adjusted EBITDA for Q4 2025 was $104.7 million, down from $116.0 million in Q4 2024 [1]. - Earnings per common share from continuing operations increased by 184.2% to $0.16, compared to a diluted loss per share of $0.19 in the prior year [1]. Annual Performance - For the year ended December 31, 2025, revenue grew by 5.1% to $5,452.8 million from $5,187.1 million in 2024 [1]. - Income from continuing operations before other income and expense increased by 25.3% to $336.2 million compared to $268.3 million in 2024 [1]. - Net income from continuing operations, net of tax, increased by 65.0% to $214.5 million from $130.0 million in the prior year [1]. - Adjusted EBITDA for the year was $493.2 million, down from $510.4 million in 2024 [1]. - Earnings per common share from continuing operations, net of tax, increased by 127.5% to $1.16, compared to $0.51 in 2024 [1]. Segment Performance - Critical Illness Recovery Hospital Segment: Q4 revenue increased by 4.9% to $629.7 million, with adjusted EBITDA rising by 5.3% to $66.4 million [2]. - Rehabilitation Hospital Segment: Q4 revenue increased by 15.2% to $339.2 million, with adjusted EBITDA increasing by 11.1% to $69.2 million [2]. - Outpatient Rehabilitation Segment: Q4 revenue increased by 1.6% to $324.6 million, but adjusted EBITDA fell to $11.2 million from $26.6 million in the prior year [2]. Business Outlook - For 2026, Select Medical expects revenue to be between $5.6 billion and $5.8 billion, with adjusted EBITDA projected between $520.0 million and $540.0 million [3]. - Fully diluted earnings per share are anticipated to range from $1.22 to $1.32 [3]. Dividend and Stock Repurchase - A cash dividend of $0.0625 per share was declared, payable on or about March 12, 2026 [2]. - The company authorized a stock repurchase program of up to $1.0 billion, with $96.5 million spent on repurchasing 6,375,512 shares in 2025 [2].